Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 5/2021

01-05-2021 | Metastasis | Original Article

Combination therapy with percutaneous osteoplasty and transcatheter arterial chemoembolization for the treatment of pelvic bone metastases: preliminary report

Authors: Lu Zhang, Benyun Wang, Pijian Cao, Qinglin Zhang, Xunwei Liu, Min Li

Published in: Supportive Care in Cancer | Issue 5/2021

Login to get access

Abstract

Purpose

To compare the clinical efficacies of percutaneous osteoplasty (POP) and combination therapy with percutaneous osteoplasty and transcatheter arterial chemoembolization (POPTACE) for the treatment of pelvic bone metastases.

Methods

A retrospective study of 100 patients with pelvic bone metastases who had been treated by POP (n = 50) and POPTACE (n = 50) was conducted in this work. The clinical efficacies of these two treatments were evaluated by comparing their pain and functional abilities and bone metastases ability at the pre- and post-operative time points.

Results

POPTACE and POP treatments had no significant differences (P > 0.05) in VAS scores and KPS scores. Concerning tumor response, a partial response in 37 of 50 (74%) patients at 1 month for the POPTACE group and a partial response in 26 of 50 (52%) patients at 1 month for the POPC group were observed (P = 0.04). Although POPTACE and POP treatments had significant and similar ability in pain relief and functional recovery ability for the treatment of pelvic bone metastases, POPTACE treatment had a significantly better tumor response ability (partial response and stable response) compared with POP treatment.

Conclusion

Both POP and POPTACE were effective methods for the treatment of pelvic bone metastases. Moreover, these initial outcomes suggest POPTACE treatment may be better than POP treatment. POPTACE treatment has great value and is worth promoting vigorously in orthopedics clinics.
Appendix
Available only for authorised users
Literature
1.
Healey JH, Brown HK (2000) Complications of bone metastases. Cancer. 88(S12):2940–2951CrossRef
2.
Picci P, Manfrini M, Fabbri N, Gambarotti M, Vanel D (2014) Atlas of musculoskeletal tumors and tumorlike lesions. Springer Publisher, BerlinCrossRef
3.
Galibert P, Deramond H (1990) Percutaneous acrylic vertebroplasty as a treatment of vertebral angioma as well as painful and debilitating diseases. Chirurgie. 116(3):326–334PubMed
4.
Kim Y-Y, Rhyu K-W (2010) Recompression of vertebral body after balloon kyphoplasty for osteoporotic vertebral compression fracture. Eur Spine J 19(11):1907–1912CrossRef
5.
Ee GWW, Lei J, Guo CM, Yeo W, Tan SB, Tow PBB, Chen LTJ, Yue WM (2015) Comparison of clinical outcomes and radiographic measurements in four different treatment modalities for osteoporotic compression fractures: retrospective analysis. J Spinal Disord Tech 28(6):E328–EE35CrossRef
6.
Chen C, Li D, Wang Z, Li T, Liu X, Zhong J (2016) Safety and efficacy studies of vertebroplasty, kyphoplasty, and mesh-container-plasty for the treatment of vertebral compression fractures: preliminary report. PLoS One 11(3):e0151492CrossRef
7.
Yevich S, Tselikas L, Gravel G, de Baere T, Deschamps F (2018) Percutaneous cement injection for the palliative treatment of osseous metastases: a technical review. Semin Interv Radiol 35(4):268–280CrossRef
8.
Liu X-w, Jin P, Liu K et al (2017) Comparison of percutaneous long bone cementoplasty with or without embedding a cement-filled catheter for painful long bone metastases with impending fracture. Eur Spine J 27(1):120–127
9.
Rosenbluth PR, Grossman R, Arias B (1960) Accurate placement of artificial emboli: a problem in the treatment of cerebral angiomas by the embolization method. J Am Med Assoc 174(3):308–309CrossRef
10.
Guan Y-S, He Q, Wang M-Q (2012) Transcatheter arterial chemoembolization: history for more than 30 years. ISRN Gastroenterol 2012:8CrossRef
11.
Chiras J, Adem C, Vallée J-N, Spelle L, Cormier E, Rose M (2004) Selective intra-arterial chemoembolization of pelvic and spine bone metastases. Eur Spine J 14(10):1774–1780
12.
Koike Y, Takizawa K, Ogawa Y, Muto A, Yoshimatsu M, Yagihashi K, Nakajima Y (2011) Transcatheter arterial chemoembolization (TACE) or embolization (TAE) for symptomatic bone metastases as a palliative treatment. Cardiovasc Interv Radiol 34(4):793–801CrossRef
13.
Fu’an W, Lifu W, Shuxiang W et al (2011) Intravascular chemoembolization combined with percutaneous vertebroplasty for the treatment of metastatic vertebral tumors: an analysis of its clinical application. J Interv Radiol 20(12):1003–1006
14.
Tian Q-H, Shi L-N, Wu C-G, Wang J, Wang J-B, Cheng Y-S (2017) Percutaneous vertebroplasty combined with transcatheter arterial infusion/chemoembolization for the treatment of spinal metastases. Iran J Radiol 14(3):1–6
15.
S Z-F, D G, H S-C, G J-H (2012) Treatment effect of combination interventional therapy on vertebral metastasis. Chin J Interv Imaging Ther 9(8):575–578
16.
Chen Y, Yan Z, Wang J, Wang X, Cheng J, Gong G, Luo J (2013) Transarterial chemoembolization for pain relief in patients with hypervascular painful metastatic spinal tumors refractory to percutaneous vertebroplasty. J Cancer Res Clin Oncol 139(8):1343–1348CrossRef
17.
Müller DA, Capanna R (2015) The surgical treatment of pelvic bone metastases. Adv Orthopedics 2015:1–10CrossRef
18.
Liu H-F, Wu C-G, Tian Q-H, Wang T, Yi F (2019) Application of percutaneous osteoplasty in treating pelvic bone metastases: efficacy and safety. Cardiovasc Interv Radiol 42(12):1738–1744
19.
Longo UG, Loppini M, Denaro L, Brandi ML, Maffulli N, Denaro V (2010) The effectiveness and safety of vertebroplasty for osteoporotic vertebral compression fractures. A double blind, prospective, randomized, controlled study. Clin Cases Miner Bone Metab 7(2):109–113PubMedPubMedCentral
20.
Yamada K, Matsumoto Y, Kita M, Yamamoto K, Kohda W, Kobayashi T, Takanaka T (2007) Clinical outcome of percutaneous osteoplasty for pain caused by metastatic bone tumors in the pelvis and femur. J Anesth 21(2):277–281CrossRef
21.
Sun G, Jin P, Liu X-w, Li M, Li L (2014) Cementoplasty for managing painful bone metastases outside the spine. Eur Spine J 24(3):731–737
22.
Ren B, Wang W, Shen J, Li W, Ni C, Zhu X (2019) Transarterial chemoembolization (TACE) combined with sorafenib versus tace alone for unresectable hepatocellular carcinoma: a propensity score matching study. J Cancer 10(5):1189–1196CrossRef
23.
Bourdel N, Alves J, Pickering G, Ramilo I, Roman H, Canis M (2015) Systematic review of endometriosis pain assessment: how to choose a scale? Hum Reprod Update 21(1):136–152CrossRef
24.
Crooks V, Waller S, Smith T, Hahn TJ (1991) The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol 46(4):M139–MM44
25.
Costelloe CM, Chuang HH, Madewell JE, Ueno NT (2010) Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST. J Cancer 1:80–92CrossRef
26.
Galibert P, Deramond H, Rosat P, Le Gars D (1987) Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty. Neurochirurgie. 33(2):166–168PubMed
27.
Dong R, Chen L, Tang T, Gu Y, Luo Z, Shi Q, Li X, Zhou Q, Yang H (2013) Pain reduction following vertebroplasty and kyphoplasty. Int Orthop 37(1):83–87CrossRef
28.
Jiao S, Subudhi SK, Aparicio A et al (2019) Differences in tumor microenvironment dictate T helper lineage polarization and response to immune checkpoint therapy. Cell 179(5):1177–90.e13CrossRef
Metadata
Title
Combination therapy with percutaneous osteoplasty and transcatheter arterial chemoembolization for the treatment of pelvic bone metastases: preliminary report
Authors
Lu Zhang
Benyun Wang
Pijian Cao
Qinglin Zhang
Xunwei Liu
Min Li
Publication date
01-05-2021
Publisher
Springer Berlin Heidelberg
Keyword
Metastasis
Published in
Supportive Care in Cancer / Issue 5/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05783-5

Other articles of this Issue 5/2021

Supportive Care in Cancer 5/2021 Go to the issue

Original Article

FIBCD1 ameliorates weight loss in chemotherapy-induced murine mucositis

Original Article

Health-related quality of life measured using EQ-5D in patients with lymphomas

Original Article

The silent transition from curative to palliative treatment: a qualitative study about cancer patients’ perceptions of end-of-life discussions with oncologists

Original Article

Cancer patient perspectives on survivorship goals from the Smart Patients online community

Original Article

Priorities to improve cancer caregiving: report of a caregiver stakeholder workshop

Original Article

Understanding benefit finding among patients with colorectal cancer: a longitudinal study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits